Similar to the ceRNA network, NR2F1-AS1 was upregulated in oxaliplatin-resistant hepatocellular carcinoma patients and promoted ABCC1 expression by targeting miR-363 to increase chemoresistance (35). The gene discussed is ABCC1; the disease is hepatocellular carcinoma.